Introduction
Peroxynitrite, a relatively stable intermediate, is formed by the diffusionlimited reaction of the free radicals nitric oxide (NO) and superoxide anion (⋅ ⋅ ⋅ ⋅O2 -) (1) (2) (3) . Inflammatory cells such as neutrophils (4) and macrophages (5) , but also endothelial cells (6) can release ⋅ ⋅ ⋅ ⋅O2 -and/or NO, potentially leading to peroxynitrite (ONOO -) formation. Peroxynitrite is a highly reactive compound with various harmful effects on cells (7) and could therefore be an important microbicidal compound.
In contrast to the possible beneficial effects of peroxynitrite in host defense mechanisms, the anion may have deleterious effects on host tissues. A role for peroxynitrite has been hypothesized in a number of disorders. Examples are human asthma (8) , acute lung injury (9) , idiopathic pulmonary fibrosis (10) , inflammatory bowel disease (11) , and animal models for septic shock (12) . Inhibition of peroxynitrite formation, by inhibiting either NO or ⋅ ⋅ ⋅ ⋅O2 -production, could be a useful tool to limit tissue damage in various circumstances.
Apocynin is a strong inhibitor of the reactive oxygen species (ROS)-generating enzyme NADPH oxidase in PMNs (13) . This NADPH oxidase complex is also present in macrophages (14, 15) and, since peroxynitrite is dependent on both NO and ⋅ ⋅ ⋅ ⋅O2 -, apocynin may also be an inhibitor of peroxynitrite formation as well. This may be of importance because, at present, specific iNOS inhibitors or peroxynitrite scavengers which can be used in vivo are not available. Apocynin has previously been demonstrated to be a powerful anti-inflammatory agent in rat models for arthritis (16), colitis (17) , and ulcerative skin lesions (18) and in a rabbit model for atherosclerosis (19) .
In this study, apocynin was tested for its ability to inhibit peroxynitrite formation by murine macrophages. Therefore, the 123-DHR oxidation assay was validated as an index of peroxynitrite formation by immuno-stimulated J774A.1 macrophages, providing a tool to screen different compounds for their ability to prevent peroxynitrite formation. Evidence for the dependence of 123-DHR oxidation on both nitric oxide and superoxide was obtained by the use of inhibitors of nitric oxide synthase (aminoguanidine) and by the superoxide scavenger TEMPO (2,2,6,6-Tetramethylpiperidin). The specificity of aminoguanidine and apocynin was confirmed by measuring lucigenin-enhanced chemiluminescence and nitrite accumulation, respectively.
Materials & Methods

Materials
Apocynin was obtained from Carl Roth GmbH (Karlsruhe, Germany) and was further purified by recrystallization from water. Murine Cell Culture J774A.1 (ATCC, Manassas, VA, USA) macrophages were maintained in RPMI 1640 (supplemented with 10% fetal bovine serum, 10 mM Hepes, 4 mM glutamate, 2 mM pyruvate, 50 µg/mL gentamycin, Penicillin/Streptomycin and 100 µM β-mercapto-ethanol, all from Gibco-BRL, Paisley, Scotland) and cultured at 37 ºC with 5% CO2. Cells were passaged every 3 days.
Oxidation of 123-Dihydrorhodamine
Cells were incubated for 20 h with or without stimuli and/or inhibitors in the presence of 25 µM 123-dihydrorhodamine (123-DHR) in culture medium in 96-well microtiter plates. After incubation, 123-DHR conversion into 123-rhodamine was measured by fluorimetric analysis at excitation/emission wavelengths of 485 and 530 nm, respectively (Cytofluor 2350, B&L Systems, Maarssen, The Netherlands). Fluorescence due to auto-oxidation of 123-DHR was subtracted from the original measurements. Furthermore, oxidation of 123-DHR by the peroxynitrite donor SIN-1 (3-morpholinosydnonimine) was measured in the presence of 300 µM apocynin or 1.0 mM aminoguanidine in culture medium (2 h, 37 ºC) as described above.
Griess assay
Nitrite concentrations were measured using the Griess reaction (20) . Briefly, 100 µL of Griess reagent (1% sulfanilamide and 0.1% naphthyl-ethylenediamide in 5% phosphoric acid) was added to 100 µL of sample medium. After a 10-min incubation at room temperature, optical density was measured at 550 nm using a microplate reader (Bio-Rad, CA, USA). Calibration curves were obtained using NaNO2 dissolved in incubation medium.
Macrophages, pre-stimulated overnight with IFNγ (50 U/mL) and LPS (10 µg/mL), were incubated in white 96-well (10 6 cells/well, 200 µL), flat-bottom microtiter plates, in the presence of lucigenin (400 µM) with and without inhibitors. Macrophages were additionally stimulated with PMA (phorbol-12-myristate-13-acetate, 10 nM). Chemiluminescence was monitored every 3 min for 0.5 s, during a period of 90 min using a Titertek luminoskan luminometer (TechGen International, Zellik, Belgium). Peak levels were used to quantitate chemiluminescence. Subsequently, the nitrite concentration in the medium was detected using the Griess assay. Experiments were performed in Hank's balanced salt solution (HBSS, Life Technologies, Paisley, Scotland) buffered at pH 7.35 with NaHCO3.
Data analysis
All data were expressed as mean ± standard error of the mean (SEM). Data were statistically analyzed using ANOVA followed by post-hoc pair-wise comparison of the effects of different inhibitor concentrations compared to control levels. Results were considered statistically different at the P < 0.05 level.
Results
Oxidation of 123-DHR and nitrite accumulation
To determine the effect of peroxynitrite formation by stimulated murine macrophages, the oxidation of 123-DHR and nitrite accumulation was assessed. Upon combined stimulation with recombinant murine IFNγ (50 U/mL) and LPS (10 µg/mL) a significant (P<0.001) increase in 123-rhodamine formation and nitrite accumulation as compared with unstimulated macrophages was detectable in the 20-h supernatants (Fig. 1) . The nitric oxide synthase inhibitor aminoguanidine dose-dependently inhibited 123-rhodamine and nitrite accumulation with logEC50 values of -3.9 ± 0.06 M (125 µM) and -3.4 ± 0.03 M (398 µM), respectively (Figs. 2 & 3) . Furthermore, the superoxide scavenger TEMPO (2,2,6,6-Tetramethylpiperidin) dose dependently inhibited 123-DHR oxidation [logEC50 -4.0 ± 0.1 M, (100 µM)] (Fig. 2) , whereas nitrite accumulation was not affected by TEMPO (Fig. 3) . The NADPH oxidase inhibitor apocynin completely inhibited 123-rhodamine accumulation [logEC50 -3.7 ± 0.03 M (199 µM)] (Fig. 2) , whereas nitrite concentrations were practically unaffected (Fig. 3) .
123-DHR oxidation by SIN-1
The peroxynitrite scavenging abilities of apocynin and aminoguanidine were investigated using the peroxynitrite donor SIN-1 (3-morpholinosydnonimine) which releases equimolar amounts of nitric oxide and superoxide anion. Neither apocynin (300 µM) nor aminoguanidine (1.0 mM) inhibited the SIN-1 mediated oxidation of 123-DHR (Fig. 4) . 
Lucigenin-enhanced chemiluminescence
Lucigenin-enhanced chemiluminescence (LUC-CL) was measured in cells pre-stimulated with IFNγ and LPS overnight and additionally stimulated with PMA (10nM) just prior to chemiluminescence measurements. Apocynin dose-dependently inhibited LUC-CL (Fig. 5 ) with a logEC50 -3.5 ± 0.1 M (316 µM). Aminoguanidine, however, did not affect LUC-CL (Fig. 5) . After the 90-min chemiluminescence incubation, nitrite measurements revealed that aminoguanidine inhibited NO output with a logEC50 of 4.7 ± 0.1 (20 µM) during this short incubation period (Fig. 6) . Apocynin did not affect nitrite accumulation in this system, not even at the highest concentration used (2 mM).
Discussion
It is important to stress that 123-DHR oxidation can only be attributed to peroxynitrite formation when shown to be dependent on both nitric oxide and superoxide anion. 123-DHR oxidation by stimulated human neutrophils, for example, is largely dependent on hydrogen peroxide formation and peroxidase activity (21) showing that 123-DHR is certainly not a specific probe for peroxynitrite. Inhibition of nitric oxide synthase by aminoguanidine revealed that the release of reactive oxygen species alone cannot explain 123-DHR oxidation measured in stimulated macrophages. Similarly, scavenging (TEMPO) or inhibition of superoxide formation (apocynin) showed that 123-DHR is insensitive to nitric oxide. Hence, 123-DHR oxidation by immuno-stimulated J774A.1 macrophages is mainly dependent on the simultaneous release of nitric oxide and superoxide anion and is therefore attributed to peroxynitrite considering the likelihood of the interaction between the two precursors (22) . Moreover, the present data suggest that NADPH oxidase is the main source of superoxide leading to peroxynitrite formation in J774A.1 macrophages since 123-DHR oxidation was completely inhibited by the NADPH oxidase inhibitor apocynin.
Neither apocynin nor aminoguanidine are scavengers of superoxide anion, nitric oxide, or peroxynitrite, since neither of the compounds inhibited SIN-1 mediated 123-DHR oxidation. SIN-1 is a donor of equimolar amounts of superoxide and nitric oxide and consequently of peroxynitrite (23) . Specificity of the inhibitors was further supported by lucigenin-enhanced chemiluminescence, which detects reactive oxygen species, but is insensitive to peroxynitrite and hypochlorous acid (24) . In this study, lucigenin-enhanced chemiluminescence could be completely blocked by apocynin, but was unaffected by aminoguanidine. The other way around, nitrite accumulation during these incubations was completely inhibited by aminoguanidine and was unaffected by apocynin.
The fact that apocynin and TEMPO did not enhance nitrite accumulation in the medium suggests that peroxynitrite mainly decays into nitrite during the incubations. The exact metabolic fate of peroxynitrite once formed in a biological environment, however, is not exactly clear at present. For example, several studies have shown an important role of carbon dioxide in peroxynitrite-mediated reactions (25) (26) (27) . Furthermore, the activities/concentrations of cellular antioxidant mechanisms are likely to play a pivotal role in downstream events initiated by peroxynitrite. Therefore, the reaction conditions for peroxynitrite and 123-DHR in the presence or inside cells may differ significantly from those in cell-free systems. For this reason, the calibration of the 123-DHR assay to exact concentrations of peroxynitrite as detected in cell-free systems may be questionable. Moreover, it is unknown whether peroxynitrite itself or downstream metabolites of the anion are responsible for the 123-DHR oxidation detected in immuno-stimulated macrophages.
Although the evidence for peroxynitrite formation in vivo is convincing, recent studies have suggested that other reactive nitrogen species maybe equally, or even more important mediators of oxidative tissue modifications during inflammatory processes (28) . The formation of the putative peroxynitrite footprint 3-nitrotyrosine, for example, has been demonstrated to be readily catalyzed by myeloperoxidase with hydrogen peroxide and nitrite as substrates (29) . Therefore, nitric oxide formation as such may not be an essential factor in reactive nitrogen species-mediated tissue alterations during inflammation. In contrast, superoxide and its downstream metabolites appear to play a pivotal role in all pathways leading to reactive nitrogen species described above. Consequently, limiting superoxide anion production by apocynin may prevent the formation of peroxynitrite as well as other reactive nitrogen species.
The present data clearly show that IFNγ and LPS-stimulated murine J774A.1 macrophages release high amounts of NO and superoxide anion, most probably leading to peroxynitrite formation. Moreover, stimulated 123-DHR oxidation by J774A.1 macrophages is dependent on both ⋅ ⋅ ⋅ ⋅O2 -and NO, and therefore likely to be dependent on peroxynitrite or downstream metabolites of peroxynitrite. This is the first time that the NADPH oxidase inhibitor apocynin is shown to be a potent inhibitor of 123-DHR oxidation by murine macrophages in vitro. Apocynin may therefore have potential therapeutic value as a tool to limit peroxynitrite formation in inflammatory conditions in vivo. Considering the lack of specific iNOS inhibitors that can be used therapeutically, apocynin could have additive value since it is not only a potent inhibitor of superoxide anion release, but also a powerful inhibitor of peroxynitrite formation.
